The Board of Directors of Sapporo Clinical Laboratory Inc. has authorized a buyback plan on February 28, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,078 JPY | -0.19% | -0.55% | +7.69% |
1st Jan change | Capi. | |
---|---|---|
+7.69% | 22.85M | |
-12.48% | 8.57B | |
+34.56% | 1.32B | |
+6.52% | 419M | |
+8.22% | 282M | |
+10.56% | 224M | |
-8.26% | 85.07M | |
+21.18% | 59.57M |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.